Pages that link to "Q39356444"
Jump to navigation
Jump to search
The following pages link to Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. (Q39356444):
Displaying 50 items.
- Regulation of Bim in Health and Disease (Q26781203) (← links)
- Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology (Q26798154) (← links)
- Splicing Regulators and Their Roles in Cancer Biology and Therapy (Q26798158) (← links)
- Misregulation of pre-mRNA alternative splicing in cancer (Q27007114) (← links)
- Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing (Q33738028) (← links)
- Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. (Q33814282) (← links)
- Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells (Q33828825) (← links)
- Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma (Q33994399) (← links)
- Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer (Q34040857) (← links)
- From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform. (Q34048030) (← links)
- Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events (Q34240895) (← links)
- The RNAissance family: SR proteins as multifaceted regulators of gene expression (Q34717851) (← links)
- Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy (Q34911031) (← links)
- Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing (Q35097083) (← links)
- A role for the serine/arginine-rich (SR) protein B52/SRSF6 in cell growth and myc expression in Drosophila (Q35342607) (← links)
- A ratiometric-based measure of gene co-expression (Q35438361) (← links)
- SRSF1 facilitates cytosolic DNA-induced production of type I interferons recognized by RIG-I. (Q35556677) (← links)
- Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage (Q35562067) (← links)
- Alternative RNA splicing and cancer (Q35589667) (← links)
- Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). (Q35641431) (← links)
- The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation (Q35736854) (← links)
- Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer (Q35993683) (← links)
- Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer (Q36047336) (← links)
- Targeting MYC in cancer therapy: RNA processing offers new opportunities (Q36762189) (← links)
- Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence (Q36772205) (← links)
- Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A (Q36850429) (← links)
- SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis (Q36870110) (← links)
- Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD (Q37166978) (← links)
- Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia. (Q38074757) (← links)
- Regulation of splicing by SR proteins and SR protein-specific kinases (Q38092678) (← links)
- Expression of Tra2 β in Cancer Cells as a Potential Contributory Factor to Neoplasia and Metastasis (Q38128295) (← links)
- Aberrant alternative splicing is another hallmark of cancer (Q38150338) (← links)
- Hallmarks of alternative splicing in cancer (Q38171229) (← links)
- MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis (Q38299040) (← links)
- Changes in splicing factor expression are associated with advancing age in man. (Q38314981) (← links)
- Deregulation of splicing factors and breast cancer development. (Q38463397) (← links)
- MYC: connecting selective transcriptional control to global RNA production. (Q38588878) (← links)
- RNA-Binding Proteins in Cancer: Old Players and New Actors. (Q38656079) (← links)
- Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify (Q38686339) (← links)
- Splicing-factor alterations in cancers (Q38929098) (← links)
- Therapeutic targeting of splicing in cancer (Q38948363) (← links)
- p53-directed translational control can shape and expand the universe of p53 target genes. (Q38985225) (← links)
- EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression (Q39109931) (← links)
- HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition (Q39124461) (← links)
- The role of RNA alternative splicing in regulating cancer metabolism. (Q39253959) (← links)
- A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1 (Q39787266) (← links)
- SRSF1 promotes vascular smooth muscle cell proliferation through a Δ133p53/EGR1/KLF5 pathway. (Q41450780) (← links)
- Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. (Q41953953) (← links)
- The spliceosome, a potential Achilles heel of MYC-driven tumors (Q42149969) (← links)
- The role of alternative splicing in cancer (Q42282317) (← links)